<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03951714</url>
  </required_header>
  <id_info>
    <org_study_id>CLI-01535AA1-01</org_study_id>
    <nct_id>NCT03951714</nct_id>
  </id_info>
  <brief_title>Effect of the Use of an add-on Device Connected to a Smartphone App on Difficult-to-treat Asthmatic Patient's Adherence</brief_title>
  <acronym>ADVICE</acronym>
  <official_title>12-wks Randomised Controlled Trial to Explore the Effect of a Smartphone App. Connected to an Add-on Device System Fitted on pMDI Inhaler on Adherence to Medications Intake and Clinical Outcomes in Difficult-to-treat Asthmatic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi Farmaceutici S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiesi Farmaceutici S.p.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this Study is to assess the effect of a smartphone application connected to an
      add-on device system fitted on Pressured Metered Dose Inhaler (PMDI) on adherence to take
      medications as prescribed and clinical outcomes in difficult-to-treat asthmatic patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in adherence rate to entire treatment period</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Adherence Rate of doses correctly taken twice daily</description>
  </primary_outcome>
  <other_outcome>
    <measure>Asthma Control Test score</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Change from Baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Test of the Adherence to Inhalers score</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Change from Baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of days without intake of rescue medication</measure>
    <time_frame>From baseline to end of participation (up to 3 months)</time_frame>
    <description>Change from Baseline</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">176</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Reference</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control experience using marketed application to record medication intake without reminders from the app</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Full experience using marketed application, with all functionalities enabled</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Marketed experience application on adherence</intervention_name>
    <description>To evaluate the effect of electronic capture of medication intake through a smartphone app on treatment's adherence</description>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_label>Reference</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient's written informed consent obtained prior to any study-related procedures

          -  Male or female patient aged 18 years and above

          -  Patient with established diagnosis of asthma for at least 6 months

          -  Patient on maintenance therapy (Fixed dose combination ICS/LABA) with high dose of ICS

          -  Patient with ACT score &lt;20 at screening and at randomization

          -  Non- or ex-smoker who smoked ≤ 10 Pack-years prior to screening

          -  Patient must have their own Android® or iPhone operating system (IOS) smartphone

          -  Ability to use the pMDI device correctly

        Exclusion Criteria:

          -  Patient with an asthma exacerbation or respiratory tract infection requiring systemic
             steroids and/or antibiotics within 1 to 3 month prior to screening

          -  Patient with a history of near-fatal asthma

          -  Clinically relevant and uncontrolled cardiac, hepatic, renal, gastrointestinal,
             endocrine, metabolic, neurologic, psychiatric or any other disorder that would put the
             safety of the subject at risk through participation, or which would affect the
             analysis

          -  Patient not able to be compliant with the study requirements.

          -  Patient with a BMI &gt; 40

          -  Patient working on night shifts

          -  Patient participating in the clinical phase of an interventional trial or have done so
             within the last 30 days prior to screening.

          -  Patient who has an already planned major surgery or hospitalization

          -  Female patient who is pregnant or lactating or who plans to become pregnant in the
             next 4 months.

          -  Patient with a history of hypersensitivity to any of the components of Foster pMDI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annaliese Linnhoff</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Medical Studies Praxis für Lungen- und Bronchialheilkunde</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chiesi Clinical Trial Info</last_name>
    <phone>+ 39 0521 279 715</phone>
    <email>clinicaltrials_info@chiesi.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barlow Medical Centre</name>
      <address>
        <city>Manchester</city>
        <zip>M20 2RN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Rogers</last_name>
      <phone>0161 445 9000</phone>
      <email>simon.rogers5@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>Rachel Britton</last_name>
      <phone>0161 445 9000</phone>
      <email>rachel.britton7@nhs.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 14, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2019</study_first_posted>
  <last_update_submitted>August 30, 2019</last_update_submitted>
  <last_update_submitted_qc>August 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post-market study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

